Skip to content
Bamboo WorksBamboo Works
Search
Register / Sign in
MSCI China 54.42 (-0.3%) | MSCI China Small-Cap 27.97 (+0.8%) | Hang Seng Index 23345.05 (-0.5%) | Hang Seng China Enterprise 8468.29 (-0.5%)
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Comirnaty vaccine

Fosun Pharma is a diversified drug company whose portfolio includes pharmaceutical, medical equipment and healthcare services.

FAST NEWS: Fosun Pharma hits pause button on share buyback program

The Latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) announced Monday it hasn't yet implemented a share buyback since announcing a plan on March 27 to buy back its A shares…
May 7, 2024
2196.HK 14.00 (+1.0%) 600196.SHG 24.02 (+1.1%)

Recent Articles

Fosun Pharma is a diversified drug company whose portfolio includes pharmaceutical, medical equipment and healthcare services.
May 7, 2024

FAST NEWS: Fosun Pharma hits pause button on share buyback program

2196.HK 14.00 (+1.0%) 600196.SHG 24.02 (+1.1%)

RECENT ARTICLES

  1. Fosun returns to financial health
    January 8, 2025
    Fosun moves on from debt crisis with renewed focus on tourism, healthcare
    0656.HK 4.29 (+0.2%)
  2. December 20, 2024
    Fosun Tourism travels back to home base with delisting plan
    1992.HK no result from real time api 0656.HK 4.29 (+0.2%)
  3. February 6, 2025
    After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
    2696.HK 39.60 (-1.0%)
  4. March 6, 2025
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK 5.89 (+3.2%)
  5. December 24, 2024
    BRIEF: Fosun pledges 27% of Fosun Pharma’s A-shares
    2196.HK 14.00 (+1.0%) 600196.SHG 24.02 (+1.1%)
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.